microbiome SER-401
Term · Oncology and biomedicine · MLC-T-ONC-015163
A donor-derived microbiome therapeutic composed of a combination of as of yet not disclosed microbes that were specifically selected to incorporate the bacterial signature found in melanoma patients who have a robust response to immunotherapy, with potential immunomodulating activity. Upon administration, SER-401 may restore the unhealthy, altered gut microbiome, enhance the microbial diversity and function in the gastrointestinal (GI) tact and may re-establish a healthy microbiome in the GI tract. This may enhance a patient's immunological activity and improve a patient's response to immunotherapy.
| Identifier | MLC-T-ONC-015163 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | microbiome-based therapeutic SER-401 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015163",
"term": "microbiome SER-401",
"field": "Oncology and biomedicine",
"definition": "A donor-derived microbiome therapeutic composed of a combination of as of yet not disclosed microbes that were specifically selected to incorporate the bacterial signature found in melanoma patients who have a robust response to immunotherapy, with potential immunomodulating activity. Upon administration, SER-401 may restore the unhealthy, altered gut microbiome, enhance the microbial diversity and function in the gastrointestinal (GI) tact and may re-establish a healthy microbiome in the GI tract. This may enhance a patient's immunological activity and improve a patient's response to immunotherapy.",
"synonyms": [
"microbiome-based therapeutic SER-401"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/microbiome-ser-401/"
}
Record 11,004 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.